Aptamer Group's Optimer binder platform

An Optimer^® is a synthetic nucleic acid-based alternative to an antibody binder. In this video, Dr. Tom Ward, presents an approach to analyzing and quantifying small molecules using the Aptamer Optimer^® binder platform. The presentation further highlights what an Optimer is, explaining its characteristics, and the diverse targets and applications of the Optimer platform, showcasing its versatility in various research areas and industries. Dr. Ward further elucidates how the platform effectively works with Optimers, detailing the mechanisms by which Optimers interact with target molecules to facilitate accurate analysis and quantification. Through this presentation, Dr. Ward offers valuable insights into the capabilities of the Optimer binder platform, highlighting its potential to enhance small molecule analysis in scientific research.